WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB), (the “Company”) said that noted Yale University School of Medicine research physician, Thomas Lentz, MD, has agreed to join the NanoViricides’ Scientific Advisory Board (SAB).
